Humanwell

Wuhan Humanwell Healthcare Co., Ltd. is a leading comprehensive pharmaceutical company in China, with decades of experience in the pharmaceutical field. It focuses on the research, development, production, and global trade of women's health medicines. Leveraging stable product quality and a comprehensive compliance system, it has become a reliable partner for many international pharmaceutical companies. Currently, the company is seeking long-term distribution and collaborative production partnerships in the Brazilian and Latin American markets. The company's core business focuses on women's health, creating a diversified product portfolio that meets international standards. Its main products include progesterone soft capsules and drospirenone ethinylestradiol tablets, which can be widely used in menstrual disorder management, pregnancy support, contraception, and polycystic ovary syndrome management, precisely meeting the Brazilian market's demand for high-quality women's health medicines. All products undergo rigorous quality control, are approved by the China National Medical Products Administration, strictly adhere to Good Manufacturing Practices (GMP) for pharmaceuticals, and comply with relevant World Health Organization standards, meeting the registration and market access requirements of the Brazilian Health Regulatory Authority. In terms of production and quality assurance, the company possesses a modern production base and a comprehensive quality testing system. From raw material procurement and production processing to finished product delivery, standardized control is implemented throughout the entire process to ensure that the purity, stability, and safety of each batch of products meet international standards. We possess extensive experience in exporting pharmaceutical products and are familiar with the trade rules, logistics processes, and compliance requirements of the Latin American market. We can provide partners with a full set of compliance documentation, including product technical data, quality testing reports, and production qualification certificates, assisting with the local registration process in Brazil and lowering the barriers to cooperation. Tailored to the characteristics of the Brazilian market, we offer flexible and diverse cooperation models, including product distribution, technology transfer, and joint production, based on partner needs. We also support small-batch trial orders to help partners quickly expand their market. Our professional international business team provides bilingual (Chinese and English) support throughout the entire process, offering one-stop service from cooperation negotiations and order execution to after-sales technical guidance, responding promptly to all partner needs. Adhering to the cooperation philosophy of "quality first, mutual benefit and win-win," we look forward to establishing in-depth cooperation with pharmaceutical distributors, pharmaceutical companies, and healthcare institutions in Brazil and Latin America to jointly expand the women's health pharmaceutical market and provide local consumers with safe and reliable healthcare solutions. Interested partners are welcome to contact us to discuss and create new opportunities for cooperation.